To the Editor We read with interest the editorial by Drs Choudhury and Katz titled “Curing Hepatitis C—Requires More Than a Prescription”1 written in response to the recent publication by Eckhardt and colleagues.2 We agree that all medical care should be delivered in destigmatized, comfortable environments and should seek to be patient centered. We agree that hepatitis C virus (HCV) treatment should be delivered in destigmatizing and supportive environments to people with opioid use disorder (OUD). An important question, as Drs Choudhury and Katz inquired, is whether the model is replicable.1 More broadly, how can vulnerable populations, such as people with OUD, receive improved health care access? One approach, such as that evaluated by Eckhardt and colleagues,2 is to physically co-locate medical treatment for HCV in venues that deliver services to people with OUD. Innovative applications of telemedicine provide alternative approaches to expand supportive, nonjudgmental health care delivery to people with OUD.3
Talal AH, Dinani A, Brown LS. Hepatitis C Virus Treatment Delivered via Telemedicine to Persons With Opioid Use Disorder. JAMA Intern Med. 2022;182(9):1011. doi:10.1001/jamainternmed.2022.2566
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.